Intellipharmaceutics (IPCI) Reports Q3 Loss of $0.08/Share

Intellipharmaceutics (NASDAQ: IPCI) reported Q3 EPS of ($0.08), versus ($0.07) reported last year. Revenue for the quarter came in at $1.2 million, versus $600 thousand reported last year.

For earnings history and earnings-related data on Intellipharmaceutics (IPCI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• CalPrivate Bank names Andra Frazier as chief credit officer
• The LGL Group (LGL) Misses Q2 EPS by 8c